<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-4654</journal-id>
<journal-title><![CDATA[Anuario mexicano de derecho internacional]]></journal-title>
<abbrev-journal-title><![CDATA[Anu. Mex. Der. Inter]]></abbrev-journal-title>
<issn>1870-4654</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Instituto de Investigaciones Jurídicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-46542023000100251</article-id>
<article-id pub-id-type="doi">10.22201/iij.24487872e.2023.23.17898</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[A governança global da saúde entre hard e soft law: Os desafios da responsabilidade social das empresas farmacêuticas]]></article-title>
<article-title xml:lang="en"><![CDATA[Global Health Governance Between Hard and Soft Law: The Challenges of Pharmaceutical Companies Social Responsibility]]></article-title>
<article-title xml:lang="fr"><![CDATA[La gouvernance de la santé mondiale entre le droit dur et le droit doux: les enjeux de la responsabilité sociale des entreprises pharmaceutiques]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pozzatti]]></surname>
<given-names><![CDATA[Ademar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[Lucas Silva de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade Federal de Santa Maria  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade Federal do Paraná  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<volume>23</volume>
<fpage>251</fpage>
<lpage>281</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-46542023000100251&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-46542023000100251&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-46542023000100251&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo O debate sobre a relação entre empresas e direitos humanos tem crescido gradualmente em sede institucional e doutrinária, bem como o reconhecimento de que faltam mecanismos para promover a responsabilidade social desses atores privados. Neste contexto, este trabalho investiga os limites e as possibilidades da responsabilidade social das empresas (RSE) farmacêuticas transnacionais pelo desigual acesso a medicamentos essenciais no Sul global, realidade agravada em contextos pandêmicos como o de HIV/AIDS e COVID-19. Para tanto, ele discute os atores, fatores e processos da governança sanitária global e debate algumas estratégias de RSE a luz daqueles elementos. Metodologicamente o trabalho faz uma revisão da literatura especializada, análise documental e de dados primários, e conduz uma abordagem normativa do tema.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The debate on the relationship between business and human rights has gradually grown in institutional and doctrinal terms, as well as the recognition that mechanisms to promote the social responsibility of these private actors are lacking. In this context, this study investigates the limits and possibilities of the corporate social responsibility (CSR) of transnational pharmaceutical companies for the unequal access to essential medicines in the global South, a reality aggravated in pandemic contexts such as HIV/AIDS and COVID-19. To this end, it discusses the actors, factors and processes of global health governance and debates some CSR strategies in the light of those elements. Methodologically, the study makes a review of the specialized literature, document and primary data analysis and conducts a normative approach of the topic.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Resume Le débat sur la relation entre les entreprises et les droits de l&#8217;homme s&#8217;est progressivement développé en termes institutionnels et doctrinaux, ainsi que la reconnaissance de l&#8217;absence de mécanismes pour promouvoir la responsabilité sociale de ces acteurs privés. Dans ce contexte, cette étude examine les limites et les possibilités de la responsabilité sociale des entreprises (RSE) pharmaceutiques transnationales pour l&#8217;accès inégal aux médicaments essentiels dans les Sud global, une réalité aggravée dans des contextes pandémiques tels que le VIH/SIDA et le COVID-19. À cette fin, il examine les acteurs, les facteurs et les processus de la gouvernance mondiale de la santé et examine certaines stratégies de RSE à la lumière de ces éléments. Méthodologiquement, le travail fait une revue de la littérature spécialisée, analyse de documents et de données primaires, et mène une approche normative du sujet.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[direito à saúde]]></kwd>
<kwd lng="pt"><![CDATA[hard law]]></kwd>
<kwd lng="pt"><![CDATA[acesso à medicamentos essenciais]]></kwd>
<kwd lng="pt"><![CDATA[responsabilidade social das empresas]]></kwd>
<kwd lng="pt"><![CDATA[soft law]]></kwd>
<kwd lng="en"><![CDATA[right to health]]></kwd>
<kwd lng="en"><![CDATA[hard law]]></kwd>
<kwd lng="en"><![CDATA[essential medicines]]></kwd>
<kwd lng="en"><![CDATA[corporate social responsibility]]></kwd>
<kwd lng="en"><![CDATA[soft law]]></kwd>
<kwd lng="fr"><![CDATA[droit à la santé]]></kwd>
<kwd lng="fr"><![CDATA[hard law]]></kwd>
<kwd lng="fr"><![CDATA[médicaments essentiels]]></kwd>
<kwd lng="fr"><![CDATA[responsabilité sociale des entreprises]]></kwd>
<kwd lng="fr"><![CDATA[soft law]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aith]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<name>
<surname><![CDATA[Diniz]]></surname>
<given-names><![CDATA[Maria Gabriela]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La Participation des acteurs non étatiques aux délibérations l&#8217;OMS: un regard sur le nouveau cadre régulatrice établi par la résolution OMS/WHA/69-10]]></article-title>
<source><![CDATA[Journal de Droit de la Santé et Assurance Maladie]]></source>
<year>2017</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basso]]></surname>
<given-names><![CDATA[Maristela]]></given-names>
</name>
<name>
<surname><![CDATA[Polido]]></surname>
<given-names><![CDATA[Fabrício]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propriedade intelectual e preços diferenciados de medicamentos essenciais: políticas de saúde pública para países em desenvolvimento]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Basso]]></surname>
<given-names><![CDATA[Maristela]]></given-names>
</name>
</person-group>
<source><![CDATA[Propriedade intelectual e preços diferenciados de medicamentos essenciais: políticas de saúde publica para países em desenvolvimento]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[ABIA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[India&#8217;s COVID crisis hits Covax vaccine-sharing scheme]]></article-title>
<source><![CDATA[BBC]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[Gressy]]></given-names>
</name>
<name>
<surname><![CDATA[Mendieta]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La adquisición de vacunas contra la COVID-19 por Colombia: entre la confidencialidad y la falta de transparência]]></article-title>
<source><![CDATA[Revista Brasileira de Políticas Públicas]]></source>
<year>2021</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chimni]]></surname>
<given-names><![CDATA[B. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Third World Approaches to International Law: a manifesto]]></article-title>
<source><![CDATA[International Community Law Review]]></source>
<year>2006</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[Jocalyn]]></given-names>
</name>
<name>
<surname><![CDATA[Mcgoey]]></surname>
<given-names><![CDATA[Linsey]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The black box warning on philanthrocapitalism]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2016</year>
<volume>388</volume>
<numero>1059</numero>
<issue>1059</issue>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delmas-Marty]]></surname>
<given-names><![CDATA[Mireille]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vers une responsabilité équitable dans une communauté mondialisée]]></article-title>
<source><![CDATA[Études]]></source>
<year></year>
<volume>1</volume>
<numero>414</numero>
<issue>414</issue>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Assim avança a vacinação país por país: rápida nos mais ricos, nem tanto nos mais pobres]]></article-title>
<source><![CDATA[El País]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eslava]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Istanbul Vignettes: Observing the Everyday Operation of International Law]]></article-title>
<source><![CDATA[London Review of International Law]]></source>
<year>2014</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fidler]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Globalization, international law, and emerging infectious diseases]]></article-title>
<source><![CDATA[Emerging Infection Diseases]]></source>
<year>1996</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fidler]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The future of the World Health Organization: What role for international law?]]></article-title>
<source><![CDATA[Vanderbilt Law Review]]></source>
<year>2021</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[Paul]]></given-names>
</name>
<name>
<surname><![CDATA[Khosla]]></surname>
<given-names><![CDATA[Rajat]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acesso a medicamentos como um direito humano]]></article-title>
<source><![CDATA[Sur. Revista Internacional de Direitos Humanos]]></source>
<year>2008</year>
<volume>5</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jouannet]]></surname>
<given-names><![CDATA[Emmanuelle]]></given-names>
</name>
</person-group>
<source><![CDATA[Le droit international]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Paris ]]></publisher-loc>
<publisher-name><![CDATA[Presses Universitaires de France]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koskenniemi]]></surname>
<given-names><![CDATA[Martti]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The politics of international law]]></article-title>
<source><![CDATA[European Journal of International Law]]></source>
<year>1990</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[One, Two, Three, Many Legal Orders: Legal Pluralism and the Cosmopolitan Dream]]></article-title>
<source><![CDATA[N.Y.U. Review of Law &amp; Social Change]]></source>
<year>2006</year>
<volume>31</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koski]]></surname>
<given-names><![CDATA[Edward]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renegotiating the Grand Bargain: Balancing Prices, Profits, People, and Principles]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[Michael]]></given-names>
</name>
<name>
<surname><![CDATA[Gorrie]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
</person-group>
<source><![CDATA[Ethics and the Pharmaceutical Industry]]></source>
<year>2005</year>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liddel]]></surname>
<given-names><![CDATA[Kathleen]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Health Impact Fund: a critique]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
<name>
<surname><![CDATA[Rimmer]]></surname>
<given-names><![CDATA[Matthew]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenstein]]></surname>
<given-names><![CDATA[Kim]]></given-names>
</name>
</person-group>
<source><![CDATA[Incentives for global public health: Patent Law and access to medicines]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin-Chenut]]></surname>
<given-names><![CDATA[Kathia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quelles responsabilités face aux exigences d&#8217;une démocratie environnementale?]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Canal-Forgues]]></surname>
<given-names><![CDATA[Eric]]></given-names>
</name>
</person-group>
<source><![CDATA[Démocratie et diplomatie environnementales: Acteurs et processus en droit international]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Paris ]]></publisher-loc>
<publisher-name><![CDATA[Pedone]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathias]]></surname>
<given-names><![CDATA[Maíra]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacêuticas: é hora de abrir a caixa preta]]></article-title>
<source><![CDATA[Outras Palavras]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<collab>Médicos Sem Fronteiras</collab>
<source><![CDATA[Pool de patentes da Unitaid: países em desenvolvimento estão sob o risco de serem excluídos]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meleu]]></surname>
<given-names><![CDATA[Marcelino]]></given-names>
</name>
<name>
<surname><![CDATA[Thaines]]></surname>
<given-names><![CDATA[Aleteia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uma resposta dworkiniana para a colisão de princípios de direitos humanos em tempos de COVID-19: direito à saúde versus direito de propriedade exclusiva sobre patentes farmacêuticas]]></article-title>
<source><![CDATA[Revista Brasileira de Políticas Públicas]]></source>
<year></year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasser]]></surname>
<given-names><![CDATA[Salem Hikmat]]></given-names>
</name>
<name>
<surname><![CDATA[Papy]]></surname>
<given-names><![CDATA[Luiza Nogueira]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID, Covax e o Refluxo da Governança Global]]></article-title>
<source><![CDATA[Revista de Direito Internacional]]></source>
<year>2021</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nwobike]]></surname>
<given-names><![CDATA[Justice]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Empresas farmacéuticas y acceso a medicamentos en los países en desarrollo: El camino a seguir]]></article-title>
<source><![CDATA[Sur. Revista Internacional de Direitos Humanos]]></source>
<year>2006</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="">
<collab>OMS</collab>
<source><![CDATA[COVID-19 response]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="">
<collab>OMS</collab>
<source><![CDATA[Improving the transparency of markets for medicines, vaccines, and other health products]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olsen]]></surname>
<given-names><![CDATA[Ana Carolina Lopes]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[Anna Luisa Walter]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diálogos multiator para implementação dos standards interamericanos sobre Pandemia e Direitos Humanos]]></article-title>
<source><![CDATA[Revista Brasileira de Políticas Públicas]]></source>
<year>2021</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="">
<collab>OXFAM Brasil</collab>
<source><![CDATA[Países ricos já compraram mais da metade do suprimento futuro da vacina contra COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿Qué es la justicia global?]]></article-title>
<source><![CDATA[Revista Latinoamericana de Filosofía]]></source>
<year>2007</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Health Impact Fund: better pharmaceutical innovations at much lower prices]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
<name>
<surname><![CDATA[Rimmer]]></surname>
<given-names><![CDATA[Matthew]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenstein]]></surname>
<given-names><![CDATA[Kim]]></given-names>
</name>
</person-group>
<source><![CDATA[Incentives for global public health: Patent Law and access to medicines]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambirdge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
<name>
<surname><![CDATA[Rimmer]]></surname>
<given-names><![CDATA[Matthew]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenstein]]></surname>
<given-names><![CDATA[Kim]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Access to essential medicines: public health and international law]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Pogge]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
<name>
<surname><![CDATA[Rimmer]]></surname>
<given-names><![CDATA[Matthew]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenstein]]></surname>
<given-names><![CDATA[Kim]]></given-names>
</name>
</person-group>
<source><![CDATA[Incentives for global public health: Patent Law and access to medicines]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambirdge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozzatti]]></surname>
<given-names><![CDATA[Ademar]]></given-names>
</name>
<name>
<surname><![CDATA[Farias]]></surname>
<given-names><![CDATA[Luiza]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O Brasil e a cooperação Sul-Americana em saúde: dos regimes temáticos às possibilidades de efetivação estruturante]]></article-title>
<source><![CDATA[Revista de Direito Internacional]]></source>
<year>2019</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozzatti]]></surname>
<given-names><![CDATA[Ademar]]></given-names>
</name>
<name>
<surname><![CDATA[Farias]]></surname>
<given-names><![CDATA[Luiza]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From emergency to structure: ways to fight COVID-19 via international cooperation from Brazil]]></article-title>
<source><![CDATA[Revista Brasileira de Política Internacional]]></source>
<year>2022</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozzatti]]></surname>
<given-names><![CDATA[Ademar]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Entre principes et procédures: Les défis de l&#8217;affaire Chevron pour la reconnaissance et la décolonialité en Amérique Latine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Tourme-Jouannet]]></surname>
<given-names><![CDATA[Emmanuelle]]></given-names>
</name>
<name>
<surname><![CDATA[Geslin]]></surname>
<given-names><![CDATA[Albane]]></given-names>
</name>
</person-group>
<source><![CDATA[Le droit international de la reconnaissance: un instrument de décolonisation et de refondation du droit international?, Aix-en-provence: Confluence des droits]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozzatti]]></surname>
<given-names><![CDATA[Ademar]]></given-names>
</name>
<name>
<surname><![CDATA[Trindade]]></surname>
<given-names><![CDATA[Igor]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O Direito Internacional entre a saúde e o comércio: estudo de caso do acesso ao medicamento Truvada como profilaxia anti-HIV/AIDS no Brasil]]></article-title>
<source><![CDATA[INTERAÇÃO]]></source>
<year>2019</year>
<volume>10</volume>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rached]]></surname>
<given-names><![CDATA[Danielle]]></given-names>
</name>
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[Deisy]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[World Health Organization and the search for accountability: a critical analysis of the new framework of engagement with non-state actors]]></article-title>
<source><![CDATA[Cadernos de Saúde Pública]]></source>
<year>2017</year>
<volume>33</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[Humberto]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Empresas y derechos humanos: ¿hacia una regulación jurídica efectiva, o el mantenimiento del status quo?]]></article-title>
<source><![CDATA[Anuario Mexicano de Derecho internacional]]></source>
<year>2013</year>
<volume>XIII</volume>
<publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez González]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Interaction between Convergent and Divergent Approaches of Global Law in the Field of Business and Human Rights]]></article-title>
<source><![CDATA[Anuario Mexicano de Derecho internacional]]></source>
<year>2021</year>
<volume>XXI</volume>
<publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[Michael A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Introduction to Part IV]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[Michael A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gorrie]]></surname>
<given-names><![CDATA[Thomas M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ethics and the Pharmaceutical Industry]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Slaughter]]></surname>
<given-names><![CDATA[Anne-Marie]]></given-names>
</name>
<name>
<surname><![CDATA[Burke-White]]></surname>
<given-names><![CDATA[William]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Future of International Law is Domestic (or, The European Way of Law)]]></article-title>
<source><![CDATA[Harvard International Law Journal]]></source>
<year>2006</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[Lucas]]></given-names>
</name>
<name>
<surname><![CDATA[Saldanha]]></surname>
<given-names><![CDATA[Jânia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O direito internacional do desenvolvimento e suas raízes imperialistas no contexto do pluralismo normativo: por um paradigma libertário e não (neo)liberal]]></article-title>
<source><![CDATA[Revista de Direito Internacional]]></source>
<year>2019</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Supiot]]></surname>
<given-names><![CDATA[Alain]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The public-private relation in the context of today&#8217;s refeudalization]]></article-title>
<source><![CDATA[International Journal of Constitutional Law]]></source>
<year>2013</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="">
<collab>UNAIDS</collab>
<source><![CDATA[Global HIV &amp; AIDS statistics - Fact sheet]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="">
<collab>UNAIDS</collab>
<source><![CDATA[Seizing the moment tackling entrenched inequalities to end epidemics]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[Deisy]]></given-names>
</name>
</person-group>
<source><![CDATA[Direito e Saúde Global: O caso da pandemia de gripe A (H1N1)]]></source>
<year>2013</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Dobra Editorial]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[Deisy]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do Ebola ao Zika: as emergências internacionais e a securitização da saúde global]]></article-title>
<source><![CDATA[Cadernos de Saúde Pública]]></source>
<year>2016</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[Deisy]]></given-names>
</name>
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[Fernanda]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Crise e reforma da organização mundial da saúde]]></article-title>
<source><![CDATA[Lua Nova]]></source>
<year>2014</year>
<volume>92</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
